Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-025903

Director sold 250 shares at $17.22 ($4,305)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnson Craig A Director 2021-04-06 Sale −250 $17.22 $4,305 3,590 D: show line 1 in the form
Open-market sales · 250 sh · avg $17.22 · $4,305
Loading xslF345X03/doc4.xml…